Please Wait...

Bioclinica expands eHealth Solutions strategic leadership team

Herne and Audibert assume key roles steering eHealth Solutions

March 24, 2016

Bioclinica®, Inc., a specialty clinical trials technology and services provider, today announced two global executive-level additions to the eHealth Solutions team. Joining the eHealth business segment leadership team are Steven Herne, chief commercial officer and Francois Audibert, vice president for global consulting.

Steve HerneSteven Herne will head Bioclinica eHealth Solutions global commercial endeavors across all three of Bioclinica's eHealth Solutions divisions comprising eClinical, Safety & Regulatory, and Financial Lifecycle Solutions. Herne was most recently chief commercial officer at ERT where he was an executive member of the global leadership team, responsible for creating and executing the long-term strategic growth plan across all business lines. Previously Herne was senior vice president, global business development at Icon where he was a member of the executive team tasked with directing the development and prioritization of business generated through key new strategic ventures. Herne was also with Covance as vice president, Europe and Asia Pacific business development where he played a key role in the development and implementation of the company's European Clinical Development business. Herne has a master's degree in Pharmaceutical Analysis from the University of Strathclyde and a bachelor's degree in Pharmacy Instrumentation from Glasgow Caledonian University.

Francois AudibertFrancois Audibert will lead Bioclinica's global consulting practice specializing in data sciences, safety system and process and will head the Company's life sciences big data strategy. Audibert, a 30-year industry veteran, is among the top thought leaders in life sciences technology. He brings a unique blend of technology, strategy and business expertise to Bioclinica, having worked on some of the world's largest drug safety implementations within a global regulatory and distribution environment. Audibert was most recently vice president of pharmacovigilance at HighPoint Solutions, and prior to this was safety solutions director at Oracle where he led the safety and surveillance teams into new offerings. Audibert is a graduate of Conservatoire National des Arts et Métiers.

"Expanding our eHealth leadership team with knowledgeable industry veterans like Steven and Francois will help steer Bioclinica's transformative industry solutions in partnership with CROs, sponsors and the broader research community," said Bioclinica eHealth Solutions President Mukhtar Ahmed.

Find out more about Bioclinica and its eHealth Solutions at www.Bioclinica.com, on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About Bioclinica
Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (Yesterday)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (2 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (4 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (4 days ago)
Kristen Mauri shows the @DIA audience the value of risk based monitoring https://t.co/ssJCfc9gQ5
bioclinica (4 days ago)
Innovation Theater Kristin Mauri of @bioclinica presenting on RBM & TQM @DrugInfoAssn #DIA2017 https://t.co/zsGroQcpiU
bioclinica (4 days ago)

Latest Blogs: